04

The California Institute for Regenerative Medicine awarded Stanford researcher Crystal Mackall a grant to study immune cells genetically modified to attack two proteins on leukemia and lymphoma cells.

Stanford scientists, focusing on chemical adjuncts affixed to DNA-associated proteins, found that these markings become more diverse with age.

In a proof-of-principle study, Stanford scientists and their colleagues used the CRISPR-Cas9 gene-editing system to modify genes in coral, suggesting that the tool could one day aid conservation efforts.

Reward centers in the brains of children and teenagers who are obese and depressed show abnormalities that suggest the two conditions are neurologically connected, Stanford researchers have found.

Stanford physicians are engaged in an ongoing and wide-ranging collaboration with the country’s ministry of health and doctors at major university-affiliated hospitals to improve several areas of cancer care.

Millions of people are slowly losing their vision to diseases of the retina, such as age-related macular degeneration. Now, a device more than a decade in the making may help some of them see again.

The Stanford event focused on what technology can do for doctors and how the medical community and other stakeholders can anticipate unexpected changes brought by artificial intelligence.

Bereaved mother Mycah Clemons raised money for a summer scholarship at Stanford for research on diffuse intrinsic pontine glioma. The move sparked a series of experiments that have led to a possible treatment for the tumor.

Eight years after being diagnosed with stage-4 lung cancer, whose treatment led to other health complications, Ginger Powell is cancer-free. “Being cared for at Stanford gives me so much hope,” she said.

A robotic assistant helped doctors detect seizures deep in Gracin Hahne’s brain without having to open her skull or even shave her head.